as on January 16, 2026 at 4:01 pm IST
Day's Low
Day's High
1.25%
Downside
2.82%
Upside
52 Week's Low
52 Week's High
51.15%
Downside
55.84%
Upside
as on January 16, 2026 at 4:01 pm IST
Market Cap
₹181.95 Cr
Return on Equity (ROE)
2.96
PE Ratio (TTM)
0Return on capital employed (ROCE)
6.38
Beta (LTM)
0.94
P/B Ratio
0.72
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-36.25
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Aarey Drugs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 181.95 | 9.61% | 0.00 | 4 | 473 | |
| NA | 168.18 | 3.59% | 0.00 | 5 | 97 | |
| NA | 20,660.00 | 21.05% | 0.00 | 115 | 1,716 | |
| NA | 3,815.88 | 107.73% | 0.00 | 183 | 653 | |
| NA | 455.95 | 15.54% | 0.00 | NA | NA |
Get share price movements and forecasts by analysts on Aarey Drugs.
Source: S&P Global Market Intelligence
Search interest for Aarey Drugs & Pharmaceuticals Ltd Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Aarey Drugs.
Aarey Drugs & Pharmaceuticals Ltd’s net profit fell -36.25% since last year same period to ₹1.02Cr in the Q2 2025-2026. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated -25.55% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 per share on 30 Nov 2018 - translating a dividend yield of 0.16%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 53.23% to 54.07% in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 44.80% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.4% return, outperforming this stock by 81.9%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.6% return, outperforming this stock by 0.3%
Price Dip
![]()
In the last 3 months, AAREYDRUGS stock has moved down by -27.0%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 1.97% to 1.13% in Sep 2025 quarter
| Organisation | Aarey Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Mihir R Ghatalia |
| E-voting on shares | Click here to vote |
Aarey Drugs share price today stands at ₹64.17 as on at the close of the market. Aarey Drugs share today touched a day high of ₹65.98 and a low of ₹63.37.
Aarey Drugs touched a 52 week high of ₹100 and a 52 week low of ₹31.35. Aarey Drugs share price today i.e. is closed at ₹64.17, which is -35.83% down from its 52 week high and 104.69% up from its 52 week low.
Aarey Drugs market capitalisation is ₹181.95 Cr as on .
To buy Aarey Drugs shares, you need to follow these steps:
Aarey Drugs trading volume is 1.70L as on . This means that 1.70L shares of Aarey Drugs were bought and sold on the stock market during today's trading session.